ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Sr. R&D IT Manager at 4D Molecular Therapeutics - ApplyBlast

Sr. R&D IT Manager

4D Molecular Therapeutics

1 day ago

3.8 on Glassdoor

Emeryville, California, United States

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Sr. R&D IT Manager provides hands-on technology leadership and serves as the IT System Owner for GxP and business-critical applications supporting 4DMT's R&D and related organizations. The role is accountable for the technical ownership, implementation, administration, integration, operation, security, support, inspection readiness, and lifecycle of assigned systems. The position requires a balanced combination of technical knowledge, GxP system lifecycle experience, and project leadership to resolve complex system-level issues and lead interdependent workstreams.

Responsibilities

Serve as IT System Owner for GxP and business-critical applications
Lead complex system implementations, upgrades, and integrations
Manage validation, inspection readiness, and lifecycle documentation

Skills

Qualifications

Bachelor's degree in Computer ScienceBachelor's degree in Information SystemsBachelor's degree in Software EngineeringAdvanced degreerelevant professional certification

About 4D Molecular Therapeutics

4dmoleculartherapeutics.com

Headquarters

Emeryville, California, United States

Company Size

51-200 employees

Founded

2013

View Profile

4D Molecular Therapeutics (4DMT) is a clinical-stage biotechnology company that designs, develops, and commercializes gene therapies for serious, unmet medical conditions. Using a proprietary AAV capsid engineering and targeted delivery platform, 4DMT creates vectors optimized for tissue specificity, potency, and manufacturability to improve safety and therapeutic benefit. The company focuses on translational programs across ocular, neuromuscular, central nervous system, and cardiopulmonary indications and partners to advance candidates toward clinical and commercial development.